News

Advances in the FARO-i project for the prevention of childhood obesity

Fruselva, together with Ingredía, the University of Barcelona (UB) and the University of the Balearic Islands (UIB), continues to advance in the FARO-i project, focused on the development of innovative and healthy products that contribute to the prevention of childhood obesity .

The research led by Fruselva has included an exhaustive systematic review of the scientific literature in various reference databases, selecting only high-quality studies to guide future trials in animals and humans. All those studies that did not meet the quality criteria established by the consortium were eliminated, e.g. animal trials with methodological limitations, studies that were not clinical trials and articles focused on other pathologies, although they were related to obesity were not included of study in FARO-i.

The project is progressing satisfactorily and the results obtained will be published soon, contributing to global progress in the field of childhood obesity. These results may contribute to the advancement of other R&D projects focused on the fight against childhood obesity, thus accelerating research in this field.

Ingredía, for its part, has led the selection of ingredients and by-products available for the consortium, prioritizing the application of the Circular Economy in the framework of the project. At the same time, intervention trials are being prepared at the UB to observe how the new developments developed by Fruselva work. Based on the results obtained, the clinical trial designed by the UIB will begin next year, in the Balearic Islands.

The FARO-i project is a consortium that brings together the groups for basic research on nutritional signaling (NCS) from the University of Barcelona and the NUCOX group from the University of the Balearic Islands and CIBER-OBN. This collaboration guarantees that each of the selected ingredients is backed by a solid scientific basis. Thanks to this comprehensive approach, progress can be made in intervention trials, with the confidence that the products developed have the potential to improve metabolic health from an early age.

Share this post:

Utilitzem cookies de tercers amb finalitats tècniques i analítiques. Si continua navegant vol dir que accepta la nostra política de cookies. Més informació,plugin cookies política de cookies.

ACEPTAR
Aviso de cookies